Immunotherapy in patients with cervical cancer
Immunotherapy, also known as therapy with immune checkpoint inhibitors, has shown good results in the treatment of both solid tumors and hematological malignancies. Patients with diseases that were considered incurable earlier now have an opportunity for long-term disease stabilization and high freq...
Saved in:
Main Author: | A. G. Kedrova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-11-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/738 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Indications of Pembrolizumab in Eight Common Cancers: Current Evidence and Future Directions
by: Raghed Mansour, et al.
Published: (2025-07-01) -
Cancer Immunotherapy: The Role of Nursing in Patient Education, Assessment, Monitoring, and Support
by: Parmis Mirzadeh, et al.
Published: (2025-07-01) -
HPV infection and the immune microenvironment in cervical cancer
by: Yibo Li, et al.
Published: (2025-07-01) -
SPECIFIC IMMUNOTHERAPY AND CELLULAR IMMUNITY IN PATIENTS WITH CERVICAL CANCER
by: D. K. Kenbaeva, et al.
Published: (2014-07-01) -
The role of immunotherapy in the treatment of skin melanoma: a contemporary perspective
by: P. S. Masaeva
Published: (2024-06-01)